| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/15/2006 | WO2006061631A1 Method of producing a palatability enhancer that can add health value to foodstuffs |
| 06/15/2006 | WO2006061628A1 Tgr3-like protein receptor |
| 06/15/2006 | WO2006061406A2 Antimicrobial peptides, polypeptides comprising same, methods for preparing same, genes coding for said peptides, vectors, transformed organisms and compositions containing same |
| 06/15/2006 | WO2006061166A1 Pure vancomycin hydrochloride |
| 06/15/2006 | WO2006060920A1 Novel uses of egf |
| 06/15/2006 | WO2006060903A1 Signal peptides, nucleic acid molecules and methods of treatment |
| 06/15/2006 | WO2006060898A1 Method for treating inflammatory disorders |
| 06/15/2006 | WO2006060873A1 Method for restoring reproductive function |
| 06/15/2006 | WO2006060871A1 Binding partners of antibodies specific for dendritic cell antigens |
| 06/15/2006 | WO2006050999A3 Methods of reducing body fat |
| 06/15/2006 | WO2006047312A9 COMPOSITIONS AND METHODS FOR MODULATING PGC-1β TO TREAT LIPID-RELATED DISEASES AND DISORDERS |
| 06/15/2006 | WO2006047214A3 Toxins and radionuclides coupled to igf-1 receptor ligands for treatment of cancer |
| 06/15/2006 | WO2006045591A3 Method and constructs for delivering double stranded rna to pest organisms |
| 06/15/2006 | WO2006043972A8 Chimeric protein |
| 06/15/2006 | WO2006041959A3 Detection of elevated levels of her-2/neu protein on circulating cancer cells and treatment |
| 06/15/2006 | WO2006034128A8 Multifunctional compounds for forming crosslinked biomaterials and methods of preparation and use |
| 06/15/2006 | WO2006030241A3 Growth factor treatment for asthma |
| 06/15/2006 | WO2006024367A3 Use of nkg2d receptor/nkg2d ligand interaction blockers in the treatment of auto-immune diseases |
| 06/15/2006 | WO2006012365A3 Protease inhibitor |
| 06/15/2006 | WO2006009920A3 Epitope analogs |
| 06/15/2006 | WO2006002387A3 Gdf3 propeptides and related methods |
| 06/15/2006 | WO2005123923A3 Inducer specific tetracycline repressor proteins and methods of use thereof |
| 06/15/2006 | WO2005114217A3 Na+ and ci> coupled transport system for endogenous opioid peptides |
| 06/15/2006 | WO2005110494A3 Methods and compositions for the inhibition of thrombus formation |
| 06/15/2006 | WO2005091801A3 Methods of protein fractionation using high performance tangential flow filtration |
| 06/15/2006 | WO2005089786A3 Y4 selective receptor agonists for therapeutic interventions |
| 06/15/2006 | WO2005080433A3 Compositions and methods for enhanced mucosal delivery of y2 receptor-binding peptides and methods for treating and preventing obesity |
| 06/15/2006 | WO2005072777A3 Conjugates of amyloid proteins as vaccines for amyloid-related diseases |
| 06/15/2006 | WO2005065718A3 Antitumour treatments with metxia-p450 and cyclophosphamide or 5t4 vaccine |
| 06/15/2006 | WO2005023176A3 Delivery of physiologixal agents with in-situ gels comprising anionic polysaccharides |
| 06/15/2006 | WO2005016371A8 IMPROVED RECOMBINANT HUMAN INTERFERON-BETA-1b POLYPEPTIDES |
| 06/15/2006 | WO2005011587A3 Chalaropsis lysozyme protein and its method of use in anti-bacterial applications |
| 06/15/2006 | WO2005007683A8 Antigen epitopes of the regulatory protein of virulence factor in staphylococcus aureus and their mimotopes and use |
| 06/15/2006 | WO2004091492A3 Computer-based model for identification and characterization of non-competitive inhibitors of nicotinic acetylcholine receptors and related ligand-gated ion channel receptors |
| 06/15/2006 | WO2004060299A3 Polymer conjugates of interferon-beta with enhanced biological potency |
| 06/15/2006 | WO2004005892A3 Antimicrobial activity of interferon-inducible elr chemokines |
| 06/15/2006 | WO2001038342A3 Novel peptide dimers as agonists of the erythropoietin (epo) receptor, and associated methods of synthesis and use |
| 06/15/2006 | US20060130164 Toll/interleukin-1 receptor adapter protein (TIRAP) |
| 06/15/2006 | US20060130158 Modified transferrin fusion proteins comprising duplicate transferrin amino or carboxy terminal domains |
| 06/15/2006 | US20060128947 Formulation, solubilization, purification, and refolding of tissue factor pathway inhibitor |
| 06/15/2006 | US20060128944 Molecular linkers suitable for crystallization and structural analysis of molecules of interest, method of using same, and methods of purifying g protein-coupled receptors |
| 06/15/2006 | US20060128943 Cross-linked polymer particles selected from (meth)acrylate polymers, styrene polymers, (meth)acrylate-styrene copolymers, and (meth)acrylate-acrylamide copolymers; produced by reacting an amino acid- or peptide chain-containing material with a compound containing a maleimidyl group; dispersibility |
| 06/15/2006 | US20060128941 Pokeweed antiviral protein polypeptides with antiviral activity |
| 06/15/2006 | US20060128754 tubulysin derivatives used as antitumor agents |
| 06/15/2006 | US20060128742 Cell migration inhibiting compositions and methods and compositions for treating cancer |
| 06/15/2006 | US20060128714 Lipoic acid, vitamin C, vitamin E, arachidonic acid, folic acid, and N-acetylcysteine as a glutathione precursor; may also contain myoinositol; hyperglycemia-associated abnormalities: increased reactive oxygen species generation, abnormal membrane phospholipid metabolism, decreased glutathione synthesis |
| 06/15/2006 | US20060128655 Use of hyaluronic acid or its derivatives to enhance delivery of antineoplastic agents |
| 06/15/2006 | US20060128650 Allele-specific RNA interference |
| 06/15/2006 | US20060128648 Preparing a suppression effector and replacement nucleic acid that have modifications in one or more third base (wobble) positions so that replacement nucleic acids still code for the wild type or equivalent amino acids |
| 06/15/2006 | US20060128647 Novel oligonucleotides and treating cardiac disorders by using the same |
| 06/15/2006 | US20060128644 Use of mob-5 in pain |
| 06/15/2006 | US20060128640 Combination of a taxane and a cyclin-dependent kinase |
| 06/15/2006 | US20060128634 Alpha, alpha-disubstituted benzylglycine derivatives as HIV protease inhibitors |
| 06/15/2006 | US20060128633 Colchinol derivatives as vascular damaging agents |
| 06/15/2006 | US20060128632 Peptide inhibitors of smac protein binding to inhibitor of apoptosis proteins (iap) |
| 06/15/2006 | US20060128631 Peptides and derivatives thereof showing cell attachment, spreading and detachment activity |
| 06/15/2006 | US20060128630 AT4 receptor ligands as angiogenic, anti-angiogenic, and anti-tumor agents |
| 06/15/2006 | US20060128629 Angiogenesis inhibitors, antitumor agents |
| 06/15/2006 | US20060128628 Human tissue antigen-binding peptides and their amino acid sequences |
| 06/15/2006 | US20060128627 Human appetite control by glucagon-like peptide receptor binding compounds |
| 06/15/2006 | US20060128626 Method of use of peptide antagonists of zonulin to prevent or delay the onset of diabetes |
| 06/15/2006 | US20060128625 A growth factor formulation comprising: a polypeptide of the TGF- beta (tranformation growth factor) superfamily, N-vinyl-2-pyrrolidone polymer carrier and a solvent selected from water and aqueous buffer solutions |
| 06/15/2006 | US20060128624 Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration |
| 06/15/2006 | US20060128623 Treating cutaneous microbial infections such as Propionibacterium acnes by administering a granulysin peptide that is modified to increase hydrophobicity |
| 06/15/2006 | US20060128622 Therapeutic formulations of keratinocyte growth factor |
| 06/15/2006 | US20060128621 Pharmaceutical composition of hydrophobically modified hedgehog proteins and their use |
| 06/15/2006 | US20060128620 Useful for therapy and prophylaxis of diseases and disorders related to ACTH, ACTH receptors or corticosteroid secretion, such as premature labor and Cushing's Disease |
| 06/15/2006 | US20060128619 Therapeutic use of modulators of notch |
| 06/15/2006 | US20060128618 Peptide binds erythropoietin receptors; for treatment of anemia and stroke |
| 06/15/2006 | US20060128617 Oligoribonucleotide or peptidic nucleic acid inhibiting function of hepatitis c virus |
| 06/15/2006 | US20060128616 Process for the purification of tnf-binding proteins using imac |
| 06/15/2006 | US20060128615 Ghrh analogues |
| 06/15/2006 | US20060128614 Antimicrobial peptides with reduced hemolysis and methods of their use |
| 06/15/2006 | US20060128613 Melanocortin receptor ligands |
| 06/15/2006 | US20060128612 Cross-linked glycopeptide-cephalosporin antibiotics |
| 06/15/2006 | US20060128611 Composition for enzyme inhibition |
| 06/15/2006 | US20060128610 Methods of treatment |
| 06/15/2006 | US20060128609 N¹- modified glycopeptides |
| 06/15/2006 | US20060128608 Novel chemical compounds and their use |
| 06/15/2006 | US20060128607 Method for inhibiting "melanoma inhibitory activity" mia |
| 06/15/2006 | US20060128606 Fibrils |
| 06/15/2006 | US20060128605 Preventives/remedies for snore or respiratory disturbances during sleep |
| 06/15/2006 | US20060128587 Lipase-containing composition and methods of use thereof |
| 06/15/2006 | US20060128016 Fibrin-containing composition |
| 06/15/2006 | US20060128003 Therapeutic agents for low HDL-cholesterolemia |
| 06/15/2006 | US20060127985 Cytokine designated 4-1BB ligand and human receptor that binds thereto |
| 06/15/2006 | US20060127983 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/15/2006 | US20060127980 Human excitatory amino acid transporter-2 gene promoter and uses thereof |
| 06/15/2006 | US20060127977 Family of mammalian G protein-coupled heteromeric receptors that specifically bind and/or are specifically activated by sweet taste stimuli such as natural and artificial sweeteners and are expressed by recombinant host cells |
| 06/15/2006 | US20060127968 Protozoan rhomboid proteins |
| 06/15/2006 | US20060127927 Mammalian IAP gene family, primers, probes, and detection methods |
| 06/15/2006 | US20060127921 PECAM-1-related molecules compositions kit of parts and associated methods of use |
| 06/15/2006 | US20060127903 Marker for cancer |
| 06/15/2006 | US20060127897 Delete sequence in m, tuberculosis, method for detecting mycobacteria using these sequences and vaccines |
| 06/15/2006 | US20060127895 Use of c-jun or c-jun activating agents such as uv or c-jun n-terminal kinases (junks) for treating cancer |
| 06/15/2006 | US20060127894 Protein associated with cell growth, differentiation, and death |
| 06/15/2006 | US20060127891 RNA interference mediated inhibition of MAP kinase gene expression or expression of genes involved in MAP kinase pathway using short interfering nucleic acid (siNA) |
| 06/15/2006 | US20060127890 Novel gene overexpressed in heart and skeletal muscle and use thereof |
| 06/15/2006 | US20060127876 Tissue engineering; prevent immune reaction when implanted |
| 06/15/2006 | US20060127873 Composition for cytocompatible, injectable, self-gelling chitosan solutions for encapsulating and delivering live cells or biologically active factors |